Evidence map›Paper›PMID 32500265›Full record

ArticleMolecular genetics and genomics : MGG2020

FCGCNMDA: predicting miRNA-disease associations by applying fully connected graph convolutional networks.

Jiashu Li, Zhengwei Li, Ru Nie, Zhuhong You, Wenzhang Bao

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular genetics and genomics : MGG, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jiashu LiSchool of Computer Science and Technology, China University of Mining and Technology, Xuzhou, 221116, China.
Zhengwei LiSchool of Computer Science and Technology, China University of Mining and Technology, Xuzhou, 221116, China. zwli@cumt.edu.cn.ORCID http://orcid.org/0000-0003-1644-1006
Ru NieSchool of Computer Science and Technology, China University of Mining and Technology, Xuzhou, 221116, China. nr@cumt.edu.cn.
Zhuhong YouXinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Science, Urumqi, 830011, China.
Wenzhang BaoSchool of Information and Electrical Engineering, Xuzhou University of Technology, Xuzhou, 221018, China.
China University of Mining and Technology · CNXinjiang Technical Institute of Physics & Chemistry · CNXuzhou University of Technology · CN

Funding

National Natural Science Foundation of China 61722212National Natural Science Foundation of China 61732012National Natural Science Foundation of China 61902337National Natural Science Foundation of China 61972399National Natural Science Foundation of China (CN) 61873270
6 · The paper itself

Abstract

Growing evidence indicates that the development and progression of multiple complex diseases are influenced by microRNA (miRNA). Identifying more miRNAs as biomarkers for clinical diagnosis, treatment and prognosis is vital to promote the development of bioinformatics and medicine. Considering that the traditional biological experimental methods are generally time-consuming and expensive, high-efficient computational methods are encouraged to uncover potential disease-related miRNAs. In this paper, FCGCNMDA is presented to predict latent miRNA-disease associations by utilizing fully connected graph convolutional networks. Specially, our method first constructs a fully connected graph in which edge weights represent correlation coefficient between any two pairs of miRNA-disease pair, and then feeds this fully connected graph along with miRNA-disease pairs feature matrix into a two-layer graph convolutional networks (GCN) for training. At last, we utilize the trained network to predict the scores for unknown miRNA-disease pairs. As a result, FCGCNMDA achieves AUC value of [Formula: see text] and AUPRC value of [Formula: see text] in HMDD v2.0 based on five-fold cross validation. Moreover, case studies on Lymphoma, Breast Neoplasms and Prostate Neoplasms shown that 98%, 98%, 98% of the top 50 selected miRNAs were validated by recent experimental evidence. From above results, we can deduce that FCGCNMDA can be regarded as reliable method for potential miRNA-disease associations prediction.

Indexed as

AlgorithmsArea Under CurveBreast NeoplasmsComputational BiologyDeep LearningEarly DiagnosisFemaleGenetic Association StudiesGenetic MarkersGenetic Predisposition to DiseaseHumansLymphomaMaleMicroRNAsPrognosisProstatic NeoplasmsGenetic MarkersMicroRNAsDeep learningFully connected graphGraph convolutional networksmiRNA-disease association

Identifiers

PMID32500265
OpenAlexW3033736933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.